Medtronic had eight patents in advanced materials during Q1 2024. Medtronic Plc has filed patents for endovascular devices with electrodes for delivering electrical stimulation to brain tissue or sensing patient parameters within blood vessels, as well as expandable elements with electrodes for cranial blood vessels. Additionally, a delivery system for prosthetic heart valves includes a shaft assembly and sheath assembly for controlled expansion or contraction of the valve structure. GlobalData’s report on Medtronic gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData


Data Insights Medtronic Plc - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

Medtronic grant share with advanced materials as a theme is 50% in Q1 2024. Grant share is based on the ratio of number of grants to total number of patents.

Recent Patents

Application: Endovascular deep brain stimulation (Patent ID: US20240075296A1)

The patent filed by Medtronic Plc describes an endovascular device with an elongated body that can be inserted into a patient's blood vessel, featuring multiple electrodes arranged in groups along the body. These electrodes can deliver electrical stimulation to brain tissue or sense patient parameters. The device includes conductors connected to the electrodes, allowing for independent activation of electrode groups and the detection of endothelization levels near the electrodes.

Furthermore, the endovascular device can transition between low-profile delivery and deployed configurations, with the electrodes facing different directions in each configuration. The device can be used in a trial mode to assess therapy efficacy, and processing circuitry controls therapy delivery based on detected endothelization levels. The patent also covers a method involving detecting endothelization levels near the electrodes, selecting stimulation parameters accordingly, and selectively delivering stimulation or sensing based on electrode groups. Overall, the patent outlines a sophisticated endovascular device with advanced capabilities for brain stimulation and patient monitoring within blood vessels.

To know more about GlobalData’s detailed insights on Medtronic, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.